PFE240920C23500
- 5.20
- 0.000.00%
Pfizer Newsroom
Pfizer Stock Rises 7.3% in 3 Months: Should You Invest Now?
Pfizer Options Spot-On: On September 18th, 112.1K Contracts Were Traded, With 3.08 Million Open Interest
On September 18th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 112.1K options for the day, of which put options accounted for 33.92% of the total transactions, and
10 Health Care Stocks With Whale Alerts In Today's Session
Weight Loss Drug Pricing Under Fire With Pills on the Horizon
Roivant Flips a Skin Drug to Organon -- Barrons.com
Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
Pfizer Inc. (PFE): Among the Best Stocks to Buy for Passive Income
Pfizer and AstraZeneca Debate: When "the Greater Good" Matters
Cramer's Lightning Round: 'Buy More' Pfizer
Pfizer Options Spot-On: On September 17th, 93,063 Contracts Were Traded, With 3.06 Million Open Interest
On September 17th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 93,063 options for the day, of which put options accounted for 29.47% of the total transactions, and
Pfizer Unusual Options Activity
Press Release: Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call With Analysts
Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $35
Jefferies analyst Akash Tewari maintains $Pfizer(PFE.US)$ with a buy rating, and maintains the target price at $35.According to TipRanks data, the analyst has a success rate of 56.8% and a total
Pfizer (PFE) Receives a Buy From Jefferies
FDA OKs Third Dose for Pfizer and Moderna Covid-19 Vaccines
Beyond The Numbers: 13 Analysts Discuss Pfizer Stock
Pfizer Options Spot-On: On September 16th, 174.99K Contracts Were Traded, With 3.09 Million Open Interest
On September 16th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 174.99K options for the day, of which put options accounted for 25.1% of the total transactions, and
Is Pfizer Stock Going to $36? 1 Wall Street Analyst Thinks So.
Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target
Pfizer Analyst Ratings